CCR-Frederick Flow Cytometry Core

CCR-Frederick 流式细胞术核心

基本信息

  • 批准号:
    8763767
  • 负责人:
  • 金额:
    $ 75.28万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

The CCR-Flow Core is an indispensable resource for NCI and contractor investigators at the Frdereick National Lab for Cancer research. Seventy investigators from 35 different laboratories have used the expertise of the flow core staff and the instrumentation available and maintained by the staff. The projects investigators have been studying include tolerization of the high-avidity T cells in the tumor microenvironment. Another study was of the critical role of tumor necrosis factor in stabilizing the CD4+Foxp3+ regulatory T cell. Regulation of the NF-B signaling pathway of pancreatic cancer stem cells was also studied. A project looking at the pivotal role of IKKalpha in spontaneous lung squamous carcinomas was also done. The influence of HLA-C expression on HIV control was also a project of study. Studies have been done on the role of DC cells in the acute infectious inflammatory process. The flow core staff has trained eighteen investigators in the first three quarters of the year to run their own samples. The instruments are used daily by the trained investigators often into the night and on the weekends. This leaves more time for the flow core staff to sort approximately 450 samples and analyze about 10419 samples in the first three quarters of this year. Without the investigators acquiring the data and analyzing their own samples, the government would have to hire full time experienced individuals to perform the same volume of work. At least 15 papers have been published, 8 papers are in press and 14 papers have been submitted in the past year using data obtained in the flow core. The future goals include keeping up with cutting-edge technology in the flow lab by expanding the pool of investigators trained to run and analyze their own samples to all of CCR in Frederick thereby expanding the use, productivity and quality of the science generated using the core's instrumentation and expertise. It is necessary to up-grade all of the instruments so that laser and fluorochrome capabilities are more interchangeable so that investigators have the flexability to use more than one instrument. This would prevent loss of data because the instrument needed was in use by another investigator or down because of needed repairs. It is critical to have this flexability in analysis of samples as well as for sorting of cells. We would also like to stay a cutting edge facility which would require at least one analyzer to be up-graded to analyze at least 28 parameters at once.
CCR-Flow Core是Frdereick国家癌症研究实验室的NCI和承包商研究人员不可或缺的资源。来自35个不同实验室的70名研究人员利用了流量核心工作人员的专业知识以及工作人员可用和维护的仪器。研究人员一直在研究的项目包括肿瘤微环境中高亲和力T细胞的耐受性。另一项研究是肿瘤坏死因子在稳定CD 4 + Foxp 3+调节性T细胞中的关键作用。还研究了胰腺癌干细胞的NF-B信号通路的调节。还完成了一个研究IKK α在自发性肺鳞状细胞癌中的关键作用的项目。HLA-C表达对艾滋病毒控制的影响也是一个研究项目。DC细胞在急性感染性炎症过程中的作用已被研究。在今年的前三个季度,流动核心工作人员已经培训了18名调查人员,让他们运行自己的样本。受过训练的调查员每天使用这些仪器,经常使用到深夜和周末。这就给流量核心人员留出了更多的时间,在今年前三个季度对约450个样本进行分类,对约10419个样本进行分析。如果没有调查人员获取数据和分析自己的样本,政府将不得不雇用全职经验丰富的个人来完成同样数量的工作。在过去一年中,至少发表了15篇论文,8篇论文正在印刷中,14篇论文是利用流动核心获得的数据提交的。未来的目标包括通过将经过培训的调查人员队伍扩大到弗雷德里克的所有CCR,从而扩大使用核心仪器和专业知识产生的科学的使用,生产力和质量,从而跟上流动实验室的尖端技术。有必要对所有仪器进行升级,使激光和荧光染料功能更具互换性,以便研究者能够灵活使用多台仪器。这将防止数据丢失,因为所需的仪器正在由另一名研究人员使用或因需要维修而停机。在样品分析以及细胞分选中具有这种灵活性至关重要。我们还希望保持先进的设施,这将需要至少一个分析仪升级到一次分析至少28个参数。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kathleen Noer其他文献

Kathleen Noer的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kathleen Noer', 18)}}的其他基金

CCR-Frederick Flow Cytometry Core
CCR-Frederick 流式细胞术核心
  • 批准号:
    8350148
  • 财政年份:
  • 资助金额:
    $ 75.28万
  • 项目类别:
CCR-Frederick Flow Cytometry Core
CCR-Frederick 流式细胞术核心
  • 批准号:
    8554117
  • 财政年份:
  • 资助金额:
    $ 75.28万
  • 项目类别:
CCR-Frederick Flow Cytometry Core
CCR-Frederick 流式细胞术核心
  • 批准号:
    9154326
  • 财政年份:
  • 资助金额:
    $ 75.28万
  • 项目类别:
CCR-Frederick Flow Cytometry Core
CCR-Frederick 流式细胞术核心
  • 批准号:
    8158374
  • 财政年份:
  • 资助金额:
    $ 75.28万
  • 项目类别:
CCR-Frederick Flow Cytometry Core
CCR-Frederick 流式细胞术核心
  • 批准号:
    8938472
  • 财政年份:
  • 资助金额:
    $ 75.28万
  • 项目类别:
CCR-Frederick Flow Cytometry Core
CCR-Frederick 流式细胞术核心
  • 批准号:
    7970050
  • 财政年份:
  • 资助金额:
    $ 75.28万
  • 项目类别:

相似海外基金

Avidityに着目した食物経口免疫療法の出口戦略
食物口服免疫疗法的退出策略以亲和力为重点
  • 批准号:
    24K19255
  • 财政年份:
    2024
  • 资助金额:
    $ 75.28万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Modulating Fibrinolysis Dynamics by Leveraging Multivalent Avidity to Control Enzyme Activity
通过利用多价亲和力控制酶活性来调节纤维蛋白溶解动力学
  • 批准号:
    10635496
  • 财政年份:
    2023
  • 资助金额:
    $ 75.28万
  • 项目类别:
Antibody avidity maturation as index for Immune resilience against SARS-CoV-2
抗体亲合力成熟作为针对 SARS-CoV-2 免疫恢复的指标
  • 批准号:
    22K15927
  • 财政年份:
    2022
  • 资助金额:
    $ 75.28万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
A novel DNA vaccine that delivers long lasting immunity by stimulating high avidity CD8 T cells and strong neutralising antibodies
一种新型 DNA 疫苗,通过刺激高亲和力 CD8 T 细胞和强中和抗体来提供持久的免疫力
  • 批准号:
    73437
  • 财政年份:
    2020
  • 资助金额:
    $ 75.28万
  • 项目类别:
    Collaborative R&D
RAPID: Effect of Avidity on Association of Fusion Inhibitory Peptides with the HRN Domain of SARS-CoV-2 Spike Protein
RAPID:亲合力对融合抑制肽与 SARS-CoV-2 刺突蛋白 HRN 结构域关联的影响
  • 批准号:
    2031167
  • 财政年份:
    2020
  • 资助金额:
    $ 75.28万
  • 项目类别:
    Standard Grant
An acoustofluidic avidity cytometer for massive parallel profiling single autoreactive T cell in autoimmune disease
用于大规模平行分析自身免疫性疾病中单个自身反应性 T 细胞的声流控亲和细胞仪
  • 批准号:
    10002377
  • 财政年份:
    2020
  • 资助金额:
    $ 75.28万
  • 项目类别:
Regulation of avidity in T lymphocytes
T 淋巴细胞亲合力的调节
  • 批准号:
    9039367
  • 财政年份:
    2016
  • 资助金额:
    $ 75.28万
  • 项目类别:
Regulation of avidity in T lymphocytes
T 淋巴细胞亲合力的调节
  • 批准号:
    9199573
  • 财政年份:
    2016
  • 资助金额:
    $ 75.28万
  • 项目类别:
The effect of oral immunotherapy on class switching and change in avidity of allergen-specific immunoglobulin
口服免疫疗法对类别转换和过敏原特异性免疫球蛋白亲合力变化的影响
  • 批准号:
    16K19648
  • 财政年份:
    2016
  • 资助金额:
    $ 75.28万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
UNS:Thermal control of avidity for separation of biologicals
UNS:生物制品分离亲合力的热控制
  • 批准号:
    1511227
  • 财政年份:
    2015
  • 资助金额:
    $ 75.28万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了